AMN
AMN Healthcare Services, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$33.80
+1.17%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.4B | 2.7B | 3.0B | 3.8B | 5.2B |
| Cost of Revenue | 2.5B | 2.0B | 2.1B | 2.5B | 3.5B |
| Gross Profit | 954.3M | 774.1M | 919.4M | 1.2B | 1.7B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 656.5M | 593.0M | 632.5M | 756.2M | 936.6M |
| General & Admin Expense | 656.5M | 593.0M | 632.5M | 756.2M | 936.6M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 137.1M | 147.9M | 389.6M | 154.9M | 133.0M |
| Total Operating Expenses | 793.6M | 740.9M | 1.0B | 911.2M | 1.1B |
| Cost and Expenses | 3.3B | 2.7B | 3.1B | 3.5B | 4.6B |
| Operating Income (EBIT) | 160.7M | 33.2M | (102.7M) | 338.4M | 647.1M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 35.6M | 45.6M | 69.9M | 54.1M | 40.4M |
| Net Interest Income | (35.6M) | (45.6M) | (69.9M) | (54.1M) | (40.4M) |
| Other Non-Op Income/Expense | 3.5M | (134.2M) | (69.9M) | (54.1M) | (40.4M) |
| Non-Operating Income (excl Interest) | (39.1M) | 88.6M | — | — | — |
| EBT (Pre-Tax Income) | 164.2M | (101.1M) | (172.6M) | 284.3M | 606.7M |
| Income Tax Expense | 59.3M | (5.4M) | (25.6M) | 73.6M | 162.7M |
| Bottom Line | |||||
| Net Income | 104.9M | (95.7M) | (147.0M) | 210.7M | 444.1M |
| Earnings from Cont. Ops | 104.9M | (95.7M) | (147.0M) | 210.7M | 444.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 104.9M | (95.7M) | (147.0M) | 210.7M | 444.1M |
| Per Share | |||||
| Basic EPS | $2.70 | ($2.48) | ($3.85) | $5.38 | $9.96 |
| Diluted EPS | $2.68 | ($2.48) | ($3.85) | $5.36 | $9.90 |
| Revenue Per Share | $88.01 | $70.88 | $78.13 | $96.73 | $117.59 |
| Shares | |||||
| Basic Shares Outstanding | 39.0M | 38.5M | 38.2M | 39.2M | 44.6M |
| Diluted Shares Outstanding | 39.7M | 38.5M | 38.2M | 39.3M | 44.9M |
| Profitability Metrics | |||||
| EBITDA | 343.9M | 101.1M | 71.1M | 499.4M | 784.2M |
| D&A | 144.1M | 156.6M | 173.8M | 160.9M | 137.1M |
| EBIT | 199.8M | (55.5M) | (102.7M) | 338.4M | 647.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026